ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,866Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 300

$617K Total Retail Price of All Prescriptions

Rank: 24 out of 300

418 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

38% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 7,753 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 795 462 S3 1 1
METOPROLOL SUCCINATE 468 299 2 6
TRIAMTERENE-HCTZ 409 208 3 118
METFORMIN HCL 394 254 4 19
FUROSEMIDE 372 292 5 3
AMLODIPINE BESYLATE 329 210 6 2
KLOR-CON M20 258 200 7 89
CLONIDINE HCL 251 184 8 50
NEXIUM 219 124 9 17
GLIMEPIRIDE 218 147 10 51
SIMVASTATIN 210 124 11 5
ZOLPIDEM TARTRATE 210 86 11 21
LEVOTHYROXINE SODIUM 179 135 13 9
POTASSIUM CHLORIDE 170 141 14 22
BENAZEPRIL HCL 169 117 15 73
BUMETANIDE 161 120 16 126
ATORVASTATIN CALCIUM 149 112 17 14
CLOPIDOGREL 147 98 18 18
CIPROFLOXACIN HCL 141 88 19 28
HYDRALAZINE HCL 140 133 20 56
CILOSTAZOL 138 101 21 182
PREDNISONE 130 83 22 33
GABAPENTIN 123 62 23 7
OMEPRAZOLE 120 74 24 11
QUINAPRIL HCL 116 93 25 128
CARVEDILOL 114 95 26 12
IBUPROFEN 106 63 27 247
LISINOPRIL 106 55 27 4
CARISOPRODOL 105 21 R 29 36
AMLODIPINE BESYLATE-BENAZEPRIL 103 71 30 52
PLAVIX 103 80 30 24
DIOVAN 101 67 32 46
TRAMADOL HCL 98 37 33 23
AMITRIPTYLINE HCL 94 43 R 34 66
TERAZOSIN HCL 90 77 35 208
AMOXICILLIN 87 64 36 142
WARFARIN SODIUM 87 65 36 10
LOSARTAN POTASSIUM 84 65 38 29
BYSTOLIC 82 42 39 59
NAPROXEN 79 37 40 243
ACETAMINOPHEN-CODEINE 79 24 S3 40 232
NAPROXEN SODIUM 79 42 40 269
CYCLOBENZAPRINE HCL 77 35 R 43 71
DIGOXIN 75 36 44 39
DOXYCYCLINE HYCLATE 73 36 45 83
PHENYTOIN SODIUM EXTENDED 71 16 46 164
SERTRALINE HCL 68 24 47 41
DICLOFENAC SODIUM 66 55 48 205
ATENOLOL-CHLORTHALIDONE 66 30 48 394
PROAIR HFA 66 26 48 138
OXYCODONE HCL-ACETAMINOPHEN 63 19 S2 51 62
ALENDRONATE SODIUM 63 32 51 61
PANTOPRAZOLE SODIUM 63 45 51 35
METOPROLOL TARTRATE 62 61 54 13
TAMSULOSIN HCL 60 60 55 8
MUPIROCIN 59 31 56 151
DIOVAN HCT 58 16 57 94
PENTOXIFYLLINE 56 42 58 420
SINGULAIR 54 23 59 114
ALPRAZOLAM 53 26 60 88
OXYBUTYNIN CHLORIDE 52 39 61 146
FLUCONAZOLE 51 20 62 224
BENAZEPRIL-HYDROCHLOROTHIAZIDE 51 23 62 439
POLYETHYLENE GLYCOL 3350 51 33 62 47
HUMALOG MIX 75-25 50 24 65 445
CLOTRIMAZOLE-BETAMETHASONE 50 37 65 445
HYDROCHLOROTHIAZIDE 50 20 65 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.